microRNA profiles of serum exosomes derived from children with nonalcoholic fatty liver

Baffy G (2015) MicroRNAs in nonalcoholic fatty liver disease. J Clin Med 4:1977–1988

Bang C, Thum T (2012) Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol 44:2060–2064

Berlanga A, Guiu-Jurado E, Porras JA, Auguet T (2014) Molecular pathways in non-alcoholic fatty liver disease. Clin Exp Gastroenterol 7:221–239

Buzzetti E, Pinzani M, Tsochatzis EA (2016) The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65:1038–1048

Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the american association for the study of liver diseases. Hepatology 67:328–357

Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A (2009) Adipogenesis and WNT signaling. Trends Endocrinol Metab 20:16–24

Csak T, Bala S, Lippai D, Satishchandran A, Catalano D, Kodys K, Szabo G (2015) microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int 35:532–541

Esler WP, Bence KK (2019) Metabolic targets in nonalcoholic fatty liver disease. Cell Mol Gastroenterol Hepatol 8:247–267

Fang YL, Chen H, Wang CL, Liang L (2018) Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model.” World J Gastroenterol 24:2974–2983

Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P (2018) Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci 75:3313–3327

Ismaiel A, Dumitrascu DL (2019) Cardiovascular risk in fatty liver disease: the liver-heart axis-literature review. Front Med (lausanne) 6:202

Kornek M, Lynch M, Mehta SH, Lai M, Exley M, Afdhal NH, Schuppan D (2012) Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology 14:3448–3458

Li S, Chen X, Zhang H, Liang X, Xiang Y, Yu C, Zen K, Li Y, Zhang CY (2009a) Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J Lipid Res 50:1756–1765

Li ZZ, Berk M, McIntyre TM, Feldstein AE (2009b) Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem 28456:37–44

Li S, Hong M, Tan HY, Wang N, Feng Y (2016) Insights into the role and interdependence of oxidative stress and inflammation in liver diseases. Oxid Med Cell Longev 2016:4234061

Lin Q, Gao Z, Alarcon RM, Ye J, Yun Z (2009) A role of miR-27 in the regulation of adipogenesis. FEBS J 27623:48–58

Liu XL, Cao HX, Fan JG (2016) MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease. J Dig Dis 17:708–715

Masarone M, Rosato V, Dallio M, Gravina AG, Aglitti A, Loguercio C, Federico A, Persico M (2018) role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxid Med Cell Longev 2018:9547613

Momen-Heravi F, Bala S, Kodys K, Szabo G (2015) Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS. Sci Rep 2015:59991

Nakanishi N, Nakagawa Y, Tokushige N, Aoki N, Matsuzaka T, Ishii K, Yahagi N, Kobayashi K, Yatoh S, Takahashi A et al (2009) The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochem Biophys Res Commun 385(4):92–96

Otsuka M, Kishikawa T, Yoshikawa T, Yamagami M, Ohno M, Takata A, Shibata C, Ishibashi R, Koike K (2017) MicroRNAs and Liver disease. J Hum Genet 62:75–80

Pappachan JM, Babu S, Krishnan B, Ravindran NC (2017) Non-alcoholic fatty liver disease: a clinical update. J Clin Transl Hepatol 5:384–393

Salvoza NC, Klinzing DC, Gopez-Cervantes J, Baclig MO (2016) Association of circulating serum miR-34a and miR-122 with dyslipidemia among patients with non-alcoholic fatty liver disease. PLoS ONE 11:e0153497

Thomou T, Mori MA, Dreyfuss JM, Konishi M, Sakaguchi M, Wolfrum C, Rao TN, Winnay JN, Garcia-Martin R, Grinspoon SK et al (2017) Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature 542:450–455

Videla LA, Pettinelli P (2012) Misregulation of PPAR functioning and its pathogenic consequences associated with nonalcoholic fatty liver disease in human obesity. PPAR Res 2012:107434

Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, Mouzaki M, Sathya P, Schwimmer JB, Sundaram SS et al (2017) NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 64:319–334

Wang T, Li M, Guan J, Li P, Wang H, Guo Y, Shuai S, Li X (2011) MicroRNAs miR-27a and miR-143 regulate porcine adipocyte lipid metabolism. Int J Mol Sci 127:950–959

Wang H, Hou L, Li A, Duan Y, Gao H, Song X (2014) Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. Biomed Res Int 2014:864894

Xing LJ, Zhang L, Liu T, Hua YQ, Zheng PY, Ji G (2011) Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver. Eur J Pharmacol 6684:67–71

Xiong WJ, Hu LJ, Jian YC, Wang LJ, Jiang M, Li W, He Y (2012) Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays. World J Gastroenterol 1817:45–52

Ying W, Riopel M, Bandyopadhyay G, Dong Y, Birmingham A, Seo JB, Ofrecio JM, Wollam J, Hernandez-Carretero A, Fu W et al (2017) Adipose tissue macrophage-derived exosomal miRNAs can modulate In Vivo? and In Vitro? insulin sensitivity. Cell 171:372-384e12

Zhang S, Ouyang X, Jiang X, Gu D, Lin Y, Kong SK, Xie W (2015) Dysregulated serum MicroRNA expression profile and potential biomarkers in hepatitis C virus-infected patients. Int J Med Sci 125:90–98

Zhang F, Li SP, Zhang T, Yu B, Zhang J, Ding HG, Ye FJ, Yuan H, Ma YY, Pan HT et al (2021) High throughput microRNAs sequencing profile of serum exosomes in women with and without polycystic ovarian syndrome. PeerJ 9:e10998

Zhou XL, Fu JF (2018) Expert consensus on the diagnosis and treatment of non-alcoholic fatty liver disease in children. Chin J Pract Pediatrics 7:487–492